These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23907575)

  • 1. Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma.
    Wu BJ; Zhou ZP; Li WP; Ding W; Wu YZ; Zhou ZW; Zhang RQ; Liu QF; Jiang H
    Tumour Biol; 2014 Jan; 35(1):123-7. PubMed ID: 23907575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
    Xu Z; Chen H; Liu D; Huo J
    Medicine (Baltimore); 2015 Apr; 94(13):e663. PubMed ID: 25837757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.
    Kanda M; Nomoto S; Okamura Y; Hayashi M; Hishida M; Fujii T; Nishikawa Y; Sugimoto H; Takeda S; Nakao A
    Mol Carcinog; 2011 Aug; 50(8):571-9. PubMed ID: 21268132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
    Cheng YY; Jin H; Liu X; Siu JM; Wong YP; Ng EK; Yu J; Leung WK; Sung JJ; Chan FK
    Br J Cancer; 2008 Dec; 99(12):2083-7. PubMed ID: 18985039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression.
    Xiao W; Wang J; Li H; Guan W; Xia D; Yu G; Xiao H; Lang B; Ma X; Liu J; Zhang X; Ye Z; Xu H
    J Urol; 2013 Jul; 190(1):291-301. PubMed ID: 23391467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
    Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
    Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.
    Xiao W; Wang J; Li H; Xia D; Yu G; Yao W; Yang Y; Xiao H; Lang B; Ma X; Guo X; Guan W; Xu H; Liu J; Zhang X; Ye Z
    BMC Cancer; 2014 Sep; 14():677. PubMed ID: 25234557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bioinformatics-Based Study on Methylation Alterations of the FBLN1 Gene in Hippocampal Tissue of Alzheimer's Disease Model DKO and DTG Mice.
    Tang R; Jian Y; Hu Z; Li L; Wang H; Miao P; Yang Z; Tang M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of several fibulin genes in prostate cancer.
    Wlazlinski A; Engers R; Hoffmann MJ; Hader C; Jung V; Müller M; Schulz WA
    Prostate; 2007 Dec; 67(16):1770-80. PubMed ID: 17929269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant hTERT promoter methylation predicts prognosis in Chinese patients with acral and mucosal melanoma: A CONSORT-compliant article.
    Xu H; Wang W; Zhao J; Li T; Kang X
    Medicine (Baltimore); 2019 Oct; 98(43):e17578. PubMed ID: 31651862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.
    Chen XH; Wu WG; Ding J
    Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.
    Lavoro A; Falzone L; Gattuso G; Conti GN; Caltabiano R; Madonna G; Capone M; McCubrey JA; Ascierto PA; Libra M; Candido S
    J Transl Med; 2024 Oct; 22(1):887. PubMed ID: 39358721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSLC1 gene silencing in cutaneous melanoma.
    You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
    Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients.
    Saelee P; Chaiwerawattana A; Ogawa K; Cho YM; Tiwawech D; Suktangman V
    Asian Pac J Cancer Prev; 2014; 15(24):10585-9. PubMed ID: 25605143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.